HOLD

8%+ dividend yield due to covered calls. When rates start turning down, these names will benefit and move higher. 71 bps, more expensive than average. Great for income, nice payment as you wait for the turnaround.

COMMENT
Defensives and interest rates.

Generally, utility stocks tend to do well when you start to get into a more recessionary environment, so 6-12 months before we anticipate a recession. Now that we're getting into the early part of the cycle, utilities and more defensive names tend to underperform. Dividend stocks have not been performing well, because interest rates are moving higher, making dividend plays appear less attractive.

At some point,  the 10-year bond yields will start to calm down, and that's when you'll start to see outperformance in utilities, dividend stocks, banks, and telcos.

SELL

Healthcare at the top, and then pharma and food. When we're seeing an early-cycle move, low vol tends to underperform. At this time, you want more cyclicals and growth. But great if you want low beta.

BUY

Long-term move from cash to digital, especially in EM. Since late 2021, performing quite nicely against the S&P 500. Drop today of $5 is not significant, secular benefits outweigh short-term moves. Hitting new highs, continues to like and add.

BUY

Likes it for cashflow and yield of 7%. Telcos have had a tough time with rising interest rates. Will do better as rates come down. 

COMMENT
Telcos -- ETFs or stocks?

He's never considered an ETF for the telecom space. Buying an ETF is a way to diversify your risk. But because telcos  tend to have lower beta than the underlying indexes, he doesn't need to buy an ETF to de-risk. 

Names to look at include BCE (owns in his portfolio), Rogers, and Telus. They'll perform better once interest rates turn over, but the good news is that you're getting a healthy dividend yield while you wait.

PAST TOP PICK
(A Top Pick Sep 08/22, Up 29%)

Very strong technical chart, with rising highs and lows. Trading above the rising 200-day MA. Outpacing the S&P 500 since late 2020. Continued constrained global oil supply, with demand picking up. Yield is 3.1%, expected to grow.

PAST TOP PICK
(A Top Pick Sep 08/22, Up 3%)

Tough place to be with rising interest rates. Yield is 5.2%. MER is 22 bps. Will rebound once interest rates start to calm down.

PAST TOP PICK
(A Top Pick Sep 08/22, Down 7%)

Likes the diversified business model. Leader. Decent valuation at 19x forward PE, with 12% earnings growth. Past year has seen a rotation out of managed care into more exciting pharma names. Stable revenues, downturn-resilient. Aging US demographics will benefit.

BUY ON WEAKNESS

Diabetes is not going away. Obesity has made its latest drug popular. Have to ask what are the side effects? Trading at 34-35x forward PE, with a 25%+ growth rate. PEG of 1.6x is not cheap, but not expensive. Overbought. He'd like to see it at the 50- or 200-day MA, around $170-175.

WAIT

Top performer of the S&P 500. Hype over AI is real, but there's been too much, and you have to look at the fundamentals. Great growth expectations of 30-35% EPS, but if there's any hiccup, the extended valuation is in jeopardy. Trades at 34x price to sales, whereas the S&P is around 2x. Tech is starting to weaken. 

He'd prefer names not so much in the limelight, like ASML or KLAC. See his Top Picks.

DON'T BUY

Uses covered calls, but also highly dependent on capital appreciation and that brings risk. Otherwise, there's no way to achieve the yield of 14-15% via covered calls + dividends. At the end of the day, it's about total return, not just income. A new offering, whose total return is worse than that of a regular financials ETF. He'd prefer a more conservative covered call strategy.

BUY

Holds banks as the top weighting, which he has no problem with, as many of the banks are undervalued now. Likes this approach. Note that 46% of the portfolio is made up of banks. Yield is 5.2%.

BUY

He holds it in more conservative portfolios. Looking back long-term, you can't get a chart that's much better. Yield is 2.1%, which he expects to remain stable and go higher over time. Expects 6.4% dividend growth, very strong. Great balance sheet and cashflow, well run. Low beta, 3/4 that of the S&P. 

BUY

Yield is 4.1% and will grow, probably about 3-4% going forward. Will probably do more share buybacks. Higher highs and lows, recently broke out. Oil supply will remain constrained, demand will steadily increase.